Hemo Organic Limited
BSE: 524590
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 0.00-100.0% | 0.00-94.7% | 0.00-99.9% | 2.41 |
| Other Income | 0.00 | 0.00 | 0.00-100.0% | 0.09 |
| Total Income | 0.00+1900.0% | 0.00-94.7% | 0.00-99.9% | 2.50 |
| EXPENSES | ||||
| Expenditure | 0.05+15.5% | 0.04-64.5% | 0.12-94.9% | 2.27 |
| Tax | 0.11+1168.9% | -0.01+64.2% | -0.03+79.2% | -0.14 |
| PROFIT | ||||
| PBT | -0.05-10.9% | -0.04+64.0% | -0.11-148.7% | 0.24 |
| Net Profit | -0.16-404.2% | -0.03+63.9% | -0.09-123.0% | 0.37 |
| KEY METRICS | ||||
| OPM % | — | -100.00% | -100.00%-106.03pp | 6.03% |
| NPM % | -100.00% | -100.00% | -100.00%-114.91pp | 14.91% |
| EPS | 0.45+400.0% | 0.09-64.0% | 0.25-76.9% | 1.08 |
Corporate Events
Board MeetingHEMORGANIC
202615Jul
Board Meeting
To consider and approve the Un-audited Financial Results of …
BSE Filing ↗ Board MeetingHEMORGANIC
202629May
Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗ Board MeetingHEMORGANIC
202511Dec
Board Meeting
Proposal for raising of funds, fixing date, place, and time …
BSE Filing ↗ Board MeetingHEMORGANIC
202529Sep
Board Meeting
Receive, consider and adopt the Audited Financial Statement …
BSE Filing ↗ Board MeetingHEMORGANIC
202513Aug
Board Meeting
Consider and approve the Un-Audited Financial Results of the…
BSE Filing ↗ Board MeetingHEMORGANIC
202520May
Board Meeting
Consider and approve the Audited Financial Results of the Co…
BSE Filing ↗ Board MeetingHEMORGANIC
202428Oct
Board Meeting
considering and approving the Un-Audited Financial Results o…
BSE Filing ↗ Board MeetingHEMORGANIC
202412Aug
Board Meeting
Consider, approve and take on record the Unaudited Standalon…
BSE Filing ↗ Board MeetingHEMORGANIC
202429May
Board Meeting
Consider and approve the audited Standalone Financial Result…
BSE Filing ↗